The government's Livestock and Dairy Development Project (LDDP) would train 300 field veterinarians from Bangladesh Agricultural University (BAU) and 300 from Chittagong Veterinary and Animal Sciences University (CVASU) to use ultrasonogram machines. A workshop on "Training on Use and Basics of Ultrasonogram Machine" was inaugurated at the conference room of the Department of Medicine of the Faculty of Veterinary Medicine on Monday. Nowfel to prioritise innovation, performance over ceremonial aspects The Department of Surgery and Obstetrics at BAU organised the workshop, funded by LDDP. BAU Vice-Chancellor Prof Dr Emdadul Haque Chowdhury was present as the chief guest at the programme, presided over by Associate Professor Dr Momena Khatun. Head, Department of Surgery and Obstetrics. Professor of the Faculty of Veterinary, Dr Md Abdul Awal, was present as a special guest. Heads of different departments and teachers of the Veterinary Faculty were also present on the occasion. Prime Minister's Gold Medalist returns awards for education in disgust over corrupt teacher recruitment process at RU The workshop was coordinated by Dr Nasrin Sultana Juyena, professor, Department of Surgery and Obstetrics. She appreciated the initiative of the government to create smart agriculture and skilled veterinarians. Venice hosts congress of Bangladeshi students in northern Italy VC Emdadul hoped to reflect the results of the training at the field level as well as emphasise enhancing the skills of the veterinarians.

A study has found people who were coronavirus infected after vaccination are at lower health risk. The study was conducted from February 7 to April 13 on 200 such cases by a team of researchers at the University of Chittagong Veterinary and Animal Sciences (CVASU). The study by CVASU found that only one infected patient died after taking the first dose of the vaccine. Read Half of US adults have received at least one COVID-19 shot According to the study, 82.5 percent of the patients did not have to go to hospital for treatment. Although 17.5 percent vaccinated yet infected patients were admitted to the hospital, no serious health risk was observed among them. More than 88 percent of 200 infected people did not have respiratory problems and 92 percent of the patients did not need oxygen. Read Are some Covid-19 vaccines more effective than others? The study showed that most of the vaccinated people became infected on average 32 days after vaccination and their average body temperature was 101 degrees.  These findings came up in the study in Chattogram region, led by Vice Chancellor Prof. Gautam Buddha Das of CVASU on the health risks of corona sufferers The study was performed on 200 infected people who had taken the first dose of Oxford-AstraZeneca vaccine produced by the Serum Institute of India. Also read: WHO calls for more research into post-Covid complications Professor Dr. Sharmin Chowdhury, Dr. Iftekhar Ahmed Rana, Dr. Trideep Das, Dr. Pranesh Dutta, Dr. Sirajul Islam and Dr. Tanvir Ahmad Nizami were among others in the research team. Only 35 of the 200 had to be hospitalized for treatment and rest of them took treatment from home. The primary symptoms of coronavirus attack are fever, sneezing and cough. The most notable symptom is shortness of breath. Most patients die from these respiratory and lung infections. However, the patients in this study showed these symptoms in a limited scale.   The positive side of the study is that only one in 200 infected patients needed to be admitted to the ICU and died after six days. Also read: Researchers find Italian woman infected with COVID-19 in November 2019: media Studies have shown that those who had shortness of breath, did not show symptoms more than five days on average. Their average oxygen saturation rate was 96.8 percent. In this regard, the head of the research team, CVASU VC Prof. Gautam Buddha Das, said that research has shown that people get infected even after vaccination but the risk of death is reduced. Only one in 200 infected people died after taking the first dose of the vaccine. This rate is 0.5 percent. However, others who take the first dose of the vaccine are better now, he added. Read Embattled Indian state looks to Bangladesh pharmas for supplies of Remdesivir